Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medro vs NuDay Rx

Medro
Graded #252

Lower grade

vs+3.3000000000000043
NuDay Rx
Graded #175

Higher grade

The verdict

NuDay Rx takes it — 66.9/100 to 63.6/100.

NuDay Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuDay Rx is a GLP-1 weight-loss telehealth service (on the CareValidate/careGLP platform) that pairs medication with video coaching and lifestyle support.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedro +2
50
48
Dose & formulationNuDay Rx +11
77
88
Clinical oversightNuDay Rx +3
71
74
Labs & monitoringNuDay Rx +10
52
62
FulfillmentMedro +19
92
73
Contract termsNuDay Rx +22
33
55
Medro · left barNuDay Rx · right bar

The numbers

MetricMedroNuDay Rx
WeighScore63.6/10066.9/100
GradeCC
Scorecard rank#252#175
Semaglutide$199/mo (compounded)$249/mo (compounded)
Tirzepatide$299/mo (compounded)$329/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Medro

Graded #252 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.
NuDay Rx

Graded #175 · C

Strengths

  • Wide selection — compounded semaglutide ($249) and tirzepatide ($329), oral tablet options, plus brand GLP-1 (cash pay)
  • Includes video coaching and lifestyle support with a licensed-doctor consult
  • Full legal suite published (Terms, Privacy, Privacy Practices, Medical Consent)
  • Prescription delivered to your door after an online intake and consult

Where it loses points

  • Compounded semaglutide ($249) is pricier than some budget competitors
  • Compounding pharmacy partner not named
  • Not LegitScript-certified (no certification displayed)
  • Runs on a shared white-label telehealth platform (CareValidate/careGLP)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard